Presented for research literature review only Kursula I et al
Chapter 7: Analyzes the market by product type, spotlighting segment-specific opportunities and helping stakeholders identify untapped, high-growth areas
Moreover, using probucol (500 mg/day, P.O for 6 months) for secondary prevention in patients with CHD lowered the incidence of the patients primary endpoint (cardiovascular disease death, hospitalization rate), which may be partly due to its strong antioxidant capacity [245]
The published clinical evidence behind GLP-1 medications as a class is substantial
If you are participating in a clinical trial or receiving retatrutide under specialist supervision, any decision to pause or stop treatment should be discussed with your study team or supervising clinician
Common side effects include nausea, constipation, or mild dizziness